Triptolide inhibits inflammatory response and migration of fibroblast like synovial cells in rheumatoid arthritis through the circRNA 0003353/JAK2/STAT3 signaling pathway.
10.12122/j.issn.1673-4254.2022.03.08
- Author:
Jie WANG
1
;
Jian LIU
1
;
Jian Ting WEN
1
;
Xin WANG
1
Author Information
1. Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China.
- Publication Type:Journal Article
- Keywords:
JAK2/STAT3;
cell migration;
circRNA 0003353;
inflammatory response;
rheumatoid arthritis;
triptolide
- MeSH:
Arthritis, Rheumatoid/pathology*;
Cells, Cultured;
Diterpenes/pharmacology*;
Epoxy Compounds/pharmacology*;
Fibroblasts/pathology*;
Humans;
Interleukin-17/metabolism*;
Interleukin-4/metabolism*;
Interleukin-6/metabolism*;
Janus Kinase 2/metabolism*;
Leukocytes, Mononuclear/metabolism*;
Phenanthrenes/pharmacology*;
RNA, Circular/metabolism*;
STAT3 Transcription Factor/metabolism*;
Signal Transduction/drug effects*;
Synovial Membrane/pathology*
- From:
Journal of Southern Medical University
2022;42(3):367-374
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect of triptolide (TPL) on inflammatory response and migration of fibroblast like synovial cells (FLS) in rheumatoid arthritis (RA-FLS) and the mechanism of circular noncoding RNA (circRNA) 0003353 for mediating this effect.
METHODS:We collected peripheral blood mononuclear cells (PBMCs) and serum samples from 50 hospitalized RA patients and 30 healthy individuals for detecting the expression of circRNA 0003353, immune and inflammatory indexes (ESR, CRP, RF, anti-CCP, IgA, IgG, IgM, C3, and C4) and DAS28 score. Cultured RA-FLS was treated with 10 ng/mL TPL and transfected with a circRNA 0003353 overexpression plasmid, and cell counting kit-8 (CCK-8) assay and Transwell assay were used to detect the changes in the viability and migration of the cells. Enzyme-linked immunosorbent assay (ELISA) was used to examine the cytokines IL-4, IL-6, and IL-17, and real-time fluorescence quantitative PCR (RT-qPCR) was performed to detect the expression of circRNA 003353; Western blotting was used to detect the expressions of p-JAK2, pSTAT3, JAK2 and STAT3 proteins in the treated cells.
RESULTS:The expression of circRNA 0003353 was significantly increased in PBMCs from RA patients and showed a good performance in assisting the diagnosis of RA (AUC=90.5%, P < 0.001, 95% CI: 0.83-0.98). CircRNA 0003353 expression was positively correlated with ESR, RF and DAS28 (P < 0.05). Treatment with TPL significantly decreased the expression of circRNA 0003353, suppressed the viability and migration ability, decreased the expressions of IL-6 and IL-17, and increased the expression IL-4 in cultured RA-FLS in a time-dependent manner (P < 0.01). TNF-α stimulation of RA-FLS significantly increased the ratios of p-JAK2/JAK2 and p-STAT3/STAT3, which were obviously lowered by TPL treatment (P < 0.01). TPL-treated RA-FLS overexpressing circRNA 0003353 showed significantly increased cell viability and migration ability with decreased IL-4 expression and increased IL-6 and IL-17 expressions and ratios of p-JAK2/ JAK2 and p-STAT3/STAT3 (P < 0.01).
CONCLUSION:The expression of circRNA 0003353 is increased in PBMCs in RA patients and in RA-FLS. TPL treatment can regulate JAK2/STAT3 signal pathway and inhibit the inflammatory response and migration of RA-FLS through circRNA 0003353.
